A new Gallup survey finds a record share of Americans are using GLP-1 medications for weight loss. Both outlets report that about 11% of Americans currently take a GLP-1 drug specifically for weight loss. The survey also indicates a sharp rise over a relatively short period: it cites that the figure was about 3% in 2024. The reports describe the increase as large and suggest growing adoption of these medications among the U.S. population for weight-management purposes. The articles reference the Gallup findings as a key data point for tracking how widespread GLP-1 use has become. While the coverage focuses mainly on the current percentage and the year-to-year change, it frames the result as reaching an all-time high based on the survey trend described. The reporting does not attribute the changes to any single cause, but it emphasizes that use for weight loss is now far more common than in prior years.